Point mutations in thepfcrtandpfmdr-1genes ofPlasmodium falciparumand clinical response to chloroquine, among malaria patients from Nigeria
- 18 July 2003
- journal article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 97 (5) , 439-451
- https://doi.org/10.1179/000349803235002489
Abstract
Chloroquine (CQ) resistance in Plasmodium falciparum has been associated with specific point mutations in the pfcrt and pfmdr-1 genes. In the present study, 30 children aged 1-12 years, who were all suffering from acute, uncomplicated, P. falciparum malaria in Ibadan, Nigeria, were evaluated to assess the association between these mutations and clinical outcome following treatment with CQ. The parasites, in blood samples collected pre-treatment and, in those who failed treatment, on the day symptoms re-occurred post-treatment, were genotyped using the polymorphic MSP1, MSP2 and GLURP loci and PCR-RFLP. The results showed that, pre-treatment, all 30 patients had polyclonal infections, the mean numbers of P. falciparum clones detected per infection being 2.6 with MSP1, 4.2 with MSP2 and 2.8 with GLURP. The T76 allele of pfcrt and the Y86 allele of pfmdr-1 were found in 53% and 40%, respectively, of the pre-treatment samples from the 15 patients who failed CQ treatment, but the Y1246 mutation in pfmdr-1 was never detected. Although the parasites from the two patients with high-grade (RIII) resistance to CQ had both of these point mutations, the presence of the T76 allele of pfcrt or the Y86 allele of pfmdr-1 (considered individually) could not be used to predict treatment outcome. However, a high frequency of clonal multiplicity may confound attempts to associate the point mutations in pfcrt or pfmdr-1 with clinical response to CQ. It remains unclear whether the present results represent the characteristics of the predominant parasite populations in the study area. Further studies are needed before the strength of the association between the point mutations identified as markers of drug resistance and clinical outcome can be accurately evaluated, in this and other regions of intense transmission.Keywords
This publication has 38 references indexed in Scilit:
- Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic areaPathogens and Global Health, 2001
- Analysis of the KeypfcrtPoint Mutation and In Vitro and In Vivo Response to Chloroquine in Yaoundé, CameroonThe Journal of Infectious Diseases, 2001
- High‐Level Chloroquine Resistance in Sudanese Isolates ofPlasmodium falciparumIs Associated with Mutations in the Chloroquine Resistance Transporter Genepfcrtand the Multidrug Resistance Genepfmdr1The Journal of Infectious Diseases, 2001
- Polymorphisms in thePlasmodium falciparum pfcrtandpfmdr‐1Genes and Clinical Response to Chloroquine in Kampala, UgandaThe Journal of Infectious Diseases, 2001
- Prevalence of the K76T Mutation in the PutativePlasmodium falciparumChloroquine Resistance Transporter(pfcrt)Gene and Its Relation to Chloroquine Resistance in MozambiqueThe Journal of Infectious Diseases, 2001
- Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparumMolecular and Biochemical Parasitology, 2001
- Plasmodium falciparumMalaria in Laos: Chloroquine Treatment Outcome and Predictive Value of Molecular MarkersThe Journal of Infectious Diseases, 2001
- Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquineParasitology, 1997
- Single-strand conformational polymorphism analysis differentiates Plasmodium falciparum treatment failures from re-infectionsMolecular and Biochemical Parasitology, 1996
- Genetic evidence that RI chloroquine resistance of Plasmodium falciparum is caused by recrudescence of resistant parasitesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994